Euthymics Bioscience, Inc. Closes $24 Million Series A Financing and Completes Acquisition of DOV Pharmaceutical
7/22/2010 6:32:38 AM
More...
|
Euthymics Bioscience, Inc. and DOV Pharmaceutical Announce Merger Agreement
7/1/2010 7:09:04 AM
More...
|
Euthymics Bioscience, Inc. Announces Letter of Intent for Acquisition of DOV Pharmaceutical
2/12/2010 11:00:10 AM
More...
|
DOV Pharmaceutical Announces Successful Restructuring of Office Lease
3/4/2008 10:21:20 AM
More...
|
DOV Pharmaceutical Announces Third Quarter Results
11/7/2007 2:23:08 PM
More...
|
DOV Pharmaceutical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
11/5/2007 12:10:21 PM
More...
|
DOV Pharmaceutical DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
9/25/2007 7:49:22 AM
More...
|
DOV Pharmaceutical Begins Trading on OTC Bulletin Board
8/29/2007 8:28:00 AM
More...
|
DOV Pharmaceutical Announces Successful Phase Ib Results for DOV 21,947
8/9/2007 11:01:25 AM
More...
|
DOV Pharmaceutical Announces Second Quarter 2007 Results
8/9/2007 9:27:16 AM
More...
|
|